Lutz joined iDx in 2020 as a member of the advisory board and has been appointed as CEO February 2021. He is an accomplished senior executive with 30+ years of executive management experience and strong entrepreneurial, international business development and corporate transaction background. He is a specialist in big data in life-sciences and healthcare, platform-oriented businesses, digital transformation and its related economic impacts to sustainable growth.
Previously he served as CEO at Molecular Health, Inc. Boston, USA and Heidelberg, Germany, a NGS based diagnostics and Bioinformatics company in the area of cancer diagnostics. Prior to that he served as CEO of a technology investment arm of a large Swiss family office consortium, Global Head of SAP’s healthcare division and EMEA Product Line Manager for Lab Automation and LIMS at Agilent Technologies. Lutz is founder of aspect.partners, an international industry advisory practice in the technology and life sciences space that advises healthcare and technology-oriented investors. He holds a master degree in Biomedical Engineering (s.c.l.) from THM Technical University of Giessen, Germany.